Published on 28/12/2025
Investigating Coating Peeling in Sustained Release Tablets Under Stress
Introduction:
The pharmaceutical industry continually seeks to enhance drug delivery systems, with sustained release tablets representing a significant advancement in this field. These tablets are designed to release active pharmaceutical ingredients (APIs) at a predetermined rate, extending their therapeutic effect and improving patient compliance. However, the integrity of these formulations is often challenged by external factors such as stress during manufacturing, packaging, and transportation. One prominent issue is coating peeling, which can compromise drug release profiles and product efficacy. Understanding and addressing the causes of coating peeling under stress is crucial for ensuring the quality and reliability of sustained release tablets.
Challenges and Issues:
- Coating peeling can lead to uneven drug release, impacting therapeutic efficacy.
- Environmental factors such as humidity and temperature fluctuations can exacerbate peeling issues.
- Improper formulation of coating materials may not adhere well under stress conditions.
- Mechanical stress during handling and packaging can initiate or worsen coating defects.
- Inconsistent application of coating materials during manufacturing can result in weak spots.
Step-by-Step Troubleshooting Guide:
- Identify the Root Cause: Begin with a detailed investigation of the manufacturing process. Examine the materials used, environmental conditions, and equipment settings to isolate potential
Regulatory Guidelines:
Compliance with regulatory standards is essential in pharmaceutical manufacturing. Agencies like the USFDA provide guidelines for the production and quality assurance of pharmaceutical products. The USFDA’s guidance on pharmaceutical manufacturing emphasizes the need for robust quality control systems and thorough documentation of manufacturing processes. Adhering to these guidelines helps ensure the safety, efficacy, and quality of sustained release tablets.
Conclusion:
Addressing coating peeling in sustained release tablets requires a holistic approach that encompasses formulation optimization, environmental control, and rigorous quality testing. By systematically troubleshooting the causes of peeling and implementing preventive measures, pharmaceutical professionals can enhance the reliability and performance of their products. Staying informed about regulatory guidelines and industry best practices is crucial for maintaining compliance and achieving excellence in tablet manufacturing. Continuous improvement and adaptation to new technologies will further strengthen the pharmaceutical industry’s ability to deliver high-quality, effective drug products.